NN’s (NASDAQ:NNBR) Q2 CY2026: Strong Sales, Stock Soars

NN (NASDAQ:NNBR) reported Q2 CY2026 results with revenue up 19.3% year over year to $128.7 million, exceeding Wall Street estimates by 10.9%. Non-GAAP adjusted EPS was $0.11, above consensus. The company guided full-year revenue to about $465 million. Shares rose 7.2% to $4.18 after the release.

Original reporting
Published Aug 5, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 10:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NN’s (NASDAQ:NNBR) Q2 CY2026: Strong Sales, Stock Soars — source image
Decision brief

The 30-second read

$NNBRBullishMed
01

Why it matters

Q2 CY2026 results beat revenue and adjusted EPS expectations, and management also claims a post-quarter balance sheet improvement, while full-year revenue guidance is roughly in line with estimates.

02

Market read

This is a company-specific earnings beat with a same-day stock reaction and an outlook near consensus, creating a tradable near-term catalyst while profitability durability remains uncertain.

03

What to watch

The article notes operating margin is still negative over five years and that EPS was affected by interest and taxes, so traders should watch for whether profitability improvement persists beyond one quarter.

Relevance 8/10Novelty 7/10Timing: after-hours/next-session setup following Q2 results and immediate +7.2% move

Background

NNBR, formerly Nuturn, supplies metal and polymer components to automotive, aerospace, medical, and industrial end markets.

Company-level read

Ticker impact

$NNBRBullishMedium confidence
Context

NNBR reported Q2 CY2026 revenue of $128.7M, up 19.3% YoY, and adjusted EPS of $0.11 above consensus, sending shares up 7.2% to $4.18.

Expected impact

Near-term bullish bias with potential follow-through if investors focus on the EPS beat and improving breakeven margin; upside may fade if guidance or profitability progress disappoints.

Evidence & confidence

The article provides concrete Q2 results (revenue, EPS) and a same-day stock reaction, but it also highlights still-negative operating margins over longer periods, limiting conviction on sustained rerating.

Market effects

Signals improving demand and cost discipline for industrial components suppliers, but does not establish a broader sector catalyst.

Primarily US small/mid-cap industrials sentiment; no explicit regional macro linkage.

No direct global supply-chain or international demand shock described.

Counterpoint

The company remains unprofitable on an operating basis over longer horizons, so the EPS beat could be less durable than the headline suggests.

Key entities

  • NNBR

    Industrial components supplier reporting Q2 CY2026 results and full-year revenue outlook.

  • Harold Bevis

    President and CEO quoted on Q2 performance and balance sheet improvement.

Related articles

$NNBRHighAI 9/10

NN INC (NNBR): Results of Operations and Financial Condition

NN INC (NNBR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pressrelease2026-q2.htm EX-99.1 PRESS RELEASE Document FOR IMMEDIATE RELEASE NN, INC. REPORTS SECOND QUARTER 2026 RESULTS NN Delivers Strong Second Quarter, Raises Outlook for 2026, Announces Refinancing 5 Pillar Growth Program Delivering Above Expectations; Data Center

$NNBRMedAI 8/10

NN (NNBR) Shares Skyrocket, What You Need To Know

NN (NASDAQ: NNBR) shares rose 11.9% after the company said it entered firearms components manufacturing via contract agreements with a leading U.S. provider. NN expects $12 million to $15 million in added sales starting in Q3, ramping through 2028, as part of a Defense and Electronics plan to reach $100 million sales in five years.

$NNBRMedAI 8/10

NN, Inc. stock rises 8% on firearms manufacturing contract win By Investing.com

NN, Inc. (NASDAQ:NNBR) shares rose about 8% after the company said it won multi-year contract manufacturing agreements to produce firearms components for a leading U.S. firearms provider. NN expects $12 million to $15 million in sales starting Q3, ramping through 2028. NN plans to update 2026 guidance with Q2 results Aug. 6; Craig-Hallum initiated Buy with a $7.00 target.

$NNBRMed

NN (NNBR) Stock Trades Up, Here Is Why

NN (NASDAQ: NNBR) shares rose about 5.6% after the company received initial purchase orders to supply components for a robotic-assisted surgery platform, following a full-facility audit at its Kentwood, Michigan plant. NN said the orders should add ~$25M to its medical new-business pipeline (to ~$75M) within a >$750M total pipeline. Stock later traded around $3.61 (+4.4%).

$NNBRMedAI 8/10

Why NN (NNBR) Stock Is Trading Lower Today

NN (NNBR) shares fell 13.9% after the company announced a $75 million private placement of common stock. NN agreed to sell 24,509,804 shares to institutional investors at $3.06 per share, increasing share count and diluting existing holders. The deal is expected to close subject to customary conditions.